Cost‐effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40–49 years
- 21 August 2006
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 97 (11), 1242-1247
- https://doi.org/10.1111/j.1349-7006.2006.00296.x
Abstract
Although the introduction of screening mammography in Japan would be expected to reduce mortality from breast cancer, the optimal screening modality in terms of cost-effectiveness remains unclear. We compared the cost-effectiveness ratio, defined as the cost required for a life-year saved, among the following three strategies: (1) annual clinical breast examination; (2) annual clinical breast examination combined with mammography; and (3) biennial clinical breast examination combined with mammography for women aged 30-79 years using a hypothetical cohort of 100 000. The sensitivity, specificity and early breast cancer rates were derived from studies conducted from 1995 to 2000 in Miyagi Prefecture. The treatment costs were based on a questionnaire survey conducted at 13 institutions in Japan. We used updated parameters that were needed in the analysis. Although the effectiveness of treatment in terms of the number of expected survival years was highest for annual combined modality, biennial combined modality had a higher cost-effectiveness ratio, followed by annual combined modality and annual clinical breast examination in all age groups. In women aged 40-49 years, annual combined modality saved 852.9 lives and the cost/survival duration was 3 394 300 yen/year, whereas for biennial combined modality the corresponding figures were 833.8 and 2 025 100 yen/year, respectively. Annual clinical breast examination did not confer any advantages in terms of effectiveness (815.5 lives saved) or cost-effectiveness (3 669 900 yen/year). While the annual combined modality was the most effective with respect to life-years saved among women aged 40-49 years, biennial combined modality was found to provide the highest cost-effectiveness.This publication has 24 references indexed in Scilit:
- A Model-Based Comparison of Breast Cancer Screening Strategies: Mammograms and Clinical Breast ExaminationsCancer Epidemiology, Biomarkers & Prevention, 2005
- A Case Control Study on the Effectiveness of Breast Cancer Screening by Clinical Breast Examination in JapanJapanese Journal of Cancer Research, 1999
- Cost-Effectiveness of Mass Screening for Breast Cancer, Using Mammography with Physical Examination, as a Function of the Screening Interval.Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening), 1999
- Appropriate Interval of Breast Cancer Screening with Mammography Based on the Rates of Early Cancer and Interval Cancer.Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening), 1996
- The cost-effectiveness of mammographic screening strategiesPublished by American Medical Association (AMA) ,1995
- Comparison of False Negative Rates among Breast Cancer Screening Modalities with or without Mammography: Miyagi TrialJapanese Journal of Cancer Research, 1995
- Quantitative Comparison Between Benefit and Risk of Mammographic Exposure in the Mass Screening of Breast Cancer for Japanese WomenNihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening), 1994
- Improved Detection Rate of Early Breast Cancer in Mass Screening Combined with MammographyJapanese Journal of Cancer Research, 1993
- Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factorsInternational Journal of Cancer, 1991
- Mass Screening for Breast Cancer: Comparison of the Clinical Stages and Prognosis of Breast Cancer Detected by Mass Screening and in Out‐patient ClinicsJapanese Journal of Cancer Research, 1989